VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today reported positive results from a bias analysis conducted for its concluded Phase 3 study of Multikine (Leukocyte ...
Building performance is a hallmark of architecture in the 21st century. With buildings and the construction industry being significant contributors to carbon emissions, designers must do everything to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results